A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape.

Peiling XieRui AnShibo YuJianjun HeHuimin Zhang

Published in: Journal of translational medicine (2021)

Overall, this study revealed five heterogeneous immune subtypes among ER+/PR-/HER2- breast cancer, also provided important implications for clinical translations.

Keyphrases

single cell
estrogen receptor
machine learning
endoplasmic reticulum
breast cancer cells
deep learning
rna seq
copy number
gene expression
breast cancer risk